Trial Profile
A Placebo- and Active-Controlled Assessment of 6- and 50-mg Oral Doxepin on Cardiac Repolarization in Healthy Volunteers: A Thorough QT Evaluation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Aug 2011
Price :
$35
*
At a glance
- Drugs Doxepin (Primary) ; Moxifloxacin
- Indications Bacterial infections; Insomnia
- Focus Pharmacodynamics
- Sponsors Ocera Therapeutics; Somaxon Pharmaceuticals
- 08 Aug 2011 New trial record
- 29 Jun 2011 Results published in the Clinical Therapeutics.